PitchBook’s Q1 2024 Medtech Report

Medtech VC investment rebounded significantly to $3.3 billion in Q1 as investors piled into high-quality companies despite historically low deal volume, PitchBook’s Q1 2024 Medtech Report explains. The largest deal went to early cancer detection startup Freenome, which raised a $254 million late-stage round led by Roche Venture Fund. Public medtech valuations have stabilized, and there are pockets of rising valuations within medical devices, consumer health, and life sciences. But exits remain hard to come by. The report dives into two areas of emerging opportunities—whole-body scans and cardiac arrest prevention and treatment—that investors should be watching.

Read the full article: PitchBook’s Q1 2024 Medtech Report //

Source: https://pitchbook.com/news/reports/q1-2024-medtech-report

Scroll to Top